For those who prefer not to use injections, semaglutide is also available in tablet form
A new study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists the class of drugs behind Ozempic, Wegovy and Mounjaro, for example may do more than regulate blood sugar and weight
Research indicates that GHK-Cu: Stimulates Collagen & Elastin Production: Increases fibroblast activity, enhancing skin firmness and reducing wrinkles
Available at: en_GB/document_library/EPAR_-_Product_Information/human/002735/ WC500165117.pdf
GLP-1 peptide molecules are simply too large to pass through the skin and enter the bloodstream through an adhesive patch, so even if a product claimed to contain real medication, the delivery method would not work
This makes KLOW more commonly discussed in research models that include inflammation-response and immune signaling pathways